Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 68,778 | 79,545 | 75,827 | 65,532 | 49,923 |
| Cost of Goods | 931 | 2,383 | 3,543 | 246 | 236 |
| Gross Profit | 67,847 | 77,162 | 72,284 | 65,286 | 49,687 |
| Operating Expenses | 97,193 | 123,860 | 90,272 | 100,254 | 99,876 |
| Operating Income | -28,415 | -46,311 | -17,445 | -34,722 | -49,957 |
| Interest Expense | 27,396 | 26,458 | 24,775 | 24,022 | 23,837 |
| Other Income | 3,149 | 1,304 | 1,222 | 741 | -123 |
| Pre-tax Income | -52,662 | -71,465 | -40,998 | -58,003 | -73,917 |
| Income Tax | 671 | 76 | 1,522 | 856 | 279 |
| Net Income Continuous | -53,333 | -71,541 | -42,520 | -58,859 | -74,196 |
| Net Income | $-53,333 | $-71,541 | $-42,520 | $-58,859 | $-74,196 |
| EPS Basic Total Ops | -0.28 | -0.38 | -0.23 | -0.32 | -0.40 |
| EPS Basic Continuous Ops | -0.28 | -0.38 | -0.23 | -0.32 | -0.40 |
| EPS Diluted Total Ops | -0.28 | -0.38 | -0.23 | -0.32 | -0.40 |
| EPS Diluted Continuous Ops | -0.28 | -0.38 | -0.23 | -0.32 | -0.40 |
| EPS Diluted Before Non-Recurring Items | -0.28 | -0.38 | -0.23 | N/A | N/A |
| EBITDA(a) | $-29,395 | $-46,878 | $-17,786 | $-34,505 | $-49,606 |